UPDATED Jun 14, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
300181 | CN¥15.42 | -1.5% | 26.1% | CN¥10.8b | n/a | PE25.3x | E22.3% | 2.9% | Pharmaceuticals & Biotech | ||
LGP | AU$0.12 | -4.2% | -32.4% | AU$34.7m | n/a | PS1.4x | E110.1% | n/a | Pharmaceuticals & Biotech | ||
GMG | AU$35.77 | 1.3% | 77.0% | AU$67.9b | AU$32.08 | PB3.9x | E35.8% | 0.8% | Real Estate | ||
ALCAP | €5.50 | -6.8% | -33.6% | €12.1m | €9.00 | PB0.2x | E112.1% | 0% | Real Estate Management and Development | ||
DETEC | €18.00 | 0% | 5.9% | €263.8m | €19.38 | PE47.9x | E26.9% | 1.3% | Tech | ||
PEN | US$187.78 | -0.6% | -44.3% | US$7.3b | US$270.83 | PE77.9x | E26.2% | n/a | Healthcare | ||
2722 | JP¥391.00 | -0.3% | 2.1% | JP¥3.0b | n/a | PB1.5x | E87.6% | 1.3% | Consumer Retailing | ||
YUBICO | kr244.00 | 3.6% | 147.2% | kr21.0b | kr265.00 | PE126.9x | E43.4% | n/a | Software | ||
AFG | kr133.20 | 0.6% | -3.8% | kr14.4b | kr100.00 | PE26.5x | E19.2% | 2.6% | Capital Goods | ||
DITTO | ฿15.20 | -3.8% | -55.0% | ฿10.5b | ฿30.00 | PE29.4x | E33.6% | 1.6% | Tech | ||
MVC | €8.16 | -2.5% | 11.8% | €1.2b | €8.02 | PS2.1x | E51.4% | 8.1% | Real Estate Management and Development | ||
DCBO | CA$51.80 | -0.9% | 3.8% | CA$1.6b | CA$62.96 | PE169.4x | E50.6% | n/a | Software | ||
BB | CA$3.23 | -12.5% | -52.0% | CA$2.0b | CA$4.79 | PS1.6x | E66.6% | n/a | Software | ||
MTRE3 | R$3.46 | -3.1% | -43.3% | R$366.0m | R$7.83 | PE5x | E58.4% | 23.5% | Real Estate Management and Development | ||
AGX | US$76.80 | 0.6% | 93.1% | US$1.0b | US$77.50 | PE26.9x | E24.9% | 1.6% | Capital Goods | ||
CARR | UK£1.48 | -1.0% | 3.9% | UK£139.7m | UK£1.66 | PB1.3x | E67.5% | 3.5% | Food, Beverage & Tobacco |